Infectious Mediastinitis Among the Strasbourg Universitary Hospital

Mediastinitis Clinical Trial

— MEDIASTINITIS  

Official title:

Infectious Mediastinitis Among the Strasbourg Universitary Hospital, a Retrospective Cohort

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05001308
• Other study ID #: 8262
• Status: Recruiting
• Start date: June 1, 2021
• Est. completion date: May 31, 2022

Study information

• Verified date: August 2021
• Source: University Hospital, Strasbourg, France
• Contact: Yvon RUCH, MD
• Phone: 33 3 69 55 12 19
• Email: yvon.ruch[@]chru-strasbourg.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Mediastinitis are rare but serious infections, with mortality rates varying from 6 to 30% according to the literature. They are essentially linked to surgical management (cardio-thoracic in particular), but some forms can be spontaneous, after extension of an ENT infectious focus, for example. Despite their seriousness, there is no strong recommendations to define their management, especially concerning antibiotic therapy and its duration. The aim of this research is to make a descriptive analysis of the cases of mediastinitis at HUS in recent years, and to study the therapeutic strategy used

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 100
• Est. completion date: May 31, 2022
• Est. primary completion date: May 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Major subject (=18 years old)
• Subject diagnosed with mediastinitis between 01/01/2010 and 31/12/2020
• Subject not having expressed his opposition, after information, to the reuse of his data for the purposes of this research.

Exclusion Criteria:

• Subject having expressed opposition to participate in the study
• Subject under guardianship, curatorship or safeguard of justice

Related Conditions & MeSH terms

• Mediastinitis

Locations

Country	Name	City	State
France	Service de maladies infectieuses et tropicales - Hôpitaux Universitaires de Strasbourg	Strasbourg

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Strasbourg, France

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Analysis of the cases of mediastinitis and the therapeutic strategy used in recent years at University Hospitals of Strasbourg		Files analysed retrospectively from January 01, 2010 to December 31, 2020 will be examined]